The Predictive Value of Fragile-site Associated Tumor Suppressor (FATS) Gene Expression on the Sensitivity of Cisplatin in Advanced Non-Small Cell Lung Cancer - Egyptian Knowledge Bank - troweb

243682

The Predictive Value of Fragile-site Associated Tumor Suppressor (FATS) Gene Expression on the Sensitivity of Cisplatin in Advanced Non-Small Cell Lung Cancer

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer

Article

Prognostic Factors of Non-Small Cell Lung Cancer and Their Relation to the Clinical Outcomes

Article

Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer

Article

Tumor-derived Vascular Endothelial Growth Factor and Angiopoietin-2 in Non-small Cell Lung Cancer

Article

Single Nucleotide Polymorphism of ERCC1 Gene in Patients with Non-Small Cell Lung Cancer and its Relation to the Response to Platinum Chemotherapy

Article

Prognostic Value of Platelet to Lymphocyte Ratio in Patients with Non-Small Cell Lung Cancer

Article

Treatment Outcomes and Prognostic Factors of Patients with Locally Advanced Non-Small Cell Lung Cancer: A Single Institution Study

Article

The Relation between Mean Platelet Volume/Platelet Count Ratio and Prognostic Factors in Patients with Advanced Non-Small Cell Lung Cancer

Article

ERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy

Article

Treatment Outcome in Patients with Metastatic Non-Small Cell Lung Cancer at Presentation (Retrospective Study)